Ensoma names new CEO

By The Science Advisory Board staff writers

October 11, 2021 -- Ensoma has named Emile Nuwaysir, PhD, as its new president and CEO.

Nuwaysir is currently chair of the Alliance for Regenerative Medicine and vice chair of Invenra, an antibody platform company he co-founded in 2011. He previously served as CEO at BlueRock Therapeutics, a Bayer Pharmaceuticals subsidiary, and will continue to chair that company's board. Before his position at BlueRock, Nuwaysir was president and CEO of Cellular Dynamics International and a member of senior management at NimbleGen Systems.

Startup Ensoma launches with gene therapy vector platform
A new genomic medicine startup called Ensoma made its corporate debut this week, raising $70 million in financing and entering into a strategic collaboration...

Copyright © 2021 scienceboard.net

Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter